Amelioration of experimental colitis by Copaxone is associated with class-II-restricted CD4 immune blocking

Autor: Gur, Chamutal, Karussis, Dimitrios, Golden, Eran, Doron, Sarit, Ilan, Yaron, Safadi, Rifaat
Zdroj: In Clinical Immunology 2006 118(2):307-316
Databáze: ScienceDirect